Assessment of Tissue Perfusion in Brain Tumor Using CT Perfusion Imaging
Main Article Content
Abstract
Background: Brain tumor grading is essential for treatment planning and prognosis, but conventional imaging may not fully characterize tumor vascularity and biological aggressiveness. CT perfusion imaging provides functional information through cerebral blood volume, cerebral blood flow, mean transit time, and perfusion score. Objective: To evaluate CT perfusion imaging parameters in patients with brain tumors and assess their association with tumor grade. Methods: This hospital-based analytical cross-sectional study included 100 patients with clinically or radiologically suspected brain tumors. CT perfusion parameters were categorized as normal or abnormal and compared between low-grade and high-grade tumors using chi-square testing. Results: Of 100 patients, 66 had low-grade and 34 had high-grade tumors. Abnormal CBV was observed in 55.9% of high-grade tumors compared with 42.4% of low-grade tumors (p=0.201). Abnormal perfusion score was present in 61.8% of high-grade tumors compared with 45.5% of low-grade tumors (p=0.122). Abnormal CBF and MTT showed minimal differences between groups, with p-values of 0.780 and 0.905, respectively. Conclusion: CT perfusion showed directional trends toward greater perfusion abnormality in high-grade tumors, particularly for CBV and perfusion score, but findings were not statistically significant. CT perfusion may provide adjunctive functional information, but larger studies using continuous parameters are required
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Jain R. Perfusion CT imaging of brain tumors: an overview. AJNR Am J Neuroradiol. 2011;32(9):1570-7.
2. Salari N, Ghasemi H, Fatahian R, Mansouri K, Dokaneheifard S, Shiri MH, et al. The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis. Eur J Med Res. 2023;28(1):39.
3. Yuan G, Miao D, Xu B, Ren M, Zou W, Zhang Z, et al. Global, regional, and national burden of brain and other central nervous system cancers from 1990 to 2021, and projections to 2035: a systematic analysis for the Global Burden of Disease Study 2021. Int J Surg. 2026;112(1):286-302.
4. Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro Oncol. 2021;23 Suppl 3:iii1-105.
5. Enam SA, Siddiqi S, Bajwa MH, Shah MM, Khalid MU. Pakistan brain tumor epidemiology study (PBTES): uncovering the hidden burden of brain tumors in the country. J Pak Med Assoc. 2022;72 Suppl 4:S2-3.
6. Al-Hussaini M, Al-Ani A, Amarin JZ, Al Sharie S, Obeidat M, Musharbash A, et al. Epidemiology and outcome of primary central nervous system tumors treated at King Hussein Cancer Center. Cancers. 2025;17(4):590.
7. Rezanejad-Asl P, Parhizkar Roudsari P, Rezaei N, Sharafkhah M, Roshandel G, Poustchi H, et al. Pre-diagnostic risk factors for brain cancer incidence and survival: insights from the Golestan Cohort Study. BMC Cancer. 2025;25(1):210.
8. Iqbal M, Sial A. Early Child Marriages, Unintended Pregnancies, and its impact on the Health of Young Girls in South Punjab. Journal of Health and Rehabilitation Research. 2023 Dec 3;3(2):272-9.
9. Iqbal M, Sial A. Knowledge, Health Practices and Policies for Hepatitis for Midwifery and Nurses in Allied and District Hospital Faisalabad. Journal of Health and Rehabilitation Research. 2023 Dec 3;3(2):286-92.
10. Comelli I, Lippi G, Campana V, Servadei F, Cervellin G. Clinical presentation and epidemiology of brain tumors firstly diagnosed in adults in the emergency department: a 10-year, single center retrospective study. Ann Transl Med. 2017;5(13):269.
11. Lan Z, Li X, Zhang X. Glioblastoma: an update in pathology, molecular mechanisms and biomarkers. Int J Mol Sci. 2024;25(5):3040.
12. Di Nallo AM, Vidiri A, Marzi S, Mirri A, Fabi A, Carapella CM, et al. Quantitative analysis of CT-perfusion parameters in the evaluation of brain gliomas and metastases. J Exp Clin Cancer Res. 2009;28(1):38.
13. Nabian N, Ghalehtaki R, Zeinalizadeh M, Balaña C, Jablonska PA. State of the neoadjuvant therapy for glioblastoma multiforme—where do we stand? Neurooncol Adv. 2024;6(1):vdae028.
14. Mousavi SE, Seyedmirzaei H, Shahrokhi Nejad S, Nejadghaderi SA. Epidemiology and socioeconomic correlates of brain and central nervous system cancers in Asia in 2020 and their projection to 2040. Sci Rep. 2024;14(1):21936.
15. Deshpande C. World Brain Tumour Day: early detection saves lives, say city doctors. Times of India. 2025 Jun 9.
16. Ostrom QT, Adel Fahmideh M, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, Bondy ML. Risk factors for childhood and adult primary brain tumors. Neuro Oncol. 2019;21(11):1357-75.
17. Zaccagna F, Grist JT, Quartuccio N, Riemer F, Fraioli F, Caracò C, et al. Imaging and treatment of brain tumors through molecular targeting: recent clinical advances. Eur J Radiol. 2021;142:109842.
18. Disawal A, Singh N. Role of CT perfusion in evaluation of brain tumors and differentiation of benign and malignant lesions. Glob J Res Anal. 2025;180-2.
19. Maarouf R, Sakr H. A potential role of CT perfusion parameters in grading of brain gliomas. Egypt J Radiol Nucl Med. 2015;46(4):1119-28.
20. Karegowda LH, Kadavigere R, Shenoy PM, Paruthikunnan SM. Efficacy of perfusion computed tomography in differentiating high-grade gliomas from low-grade gliomas, lymphomas, metastases and abscess. J Clin Diagn Res. 2017;11(5):TC28.
21. Wang K, Li Y, Cheng H, Li S, Xiang W, Ming Y, et al. Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status. BMC Neurol. 2021;21(1):460.
22. Onishi S, Kajiwara Y, Takayasu T, Kolakshyapati M, Ishifuro M, Amatya VJ, et al. Perfusion computed tomography parameters are useful for differentiating glioblastoma, lymphoma, and metastasis. World Neurosurg. 2018;119:e890-7.
23. Yeung TPC, Bauman G, Yartsev S, Fainardi E, Macdonald D, Lee TY. Dynamic perfusion CT in brain tumors. Eur J Radiol. 2015;84(12):2386-92.
24. Ellika SK, Jain R, Patel SC, Scarpace L, Schultz LR, Rock JP, et al. Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. AJNR Am J Neuroradiol. 2007;28(10):1981-7.
25. Greenlaw K, Shiva Shankar JJ. Correlation of CT and MR perfusion and permeability parameters for intracranial tumors. OBM Neurobiol. 2019;3(1):1-9.
26. Satheesh Kumar E. The role of CT perfusion parameters in grading of brain gliomas in correlation with histopathology [dissertation]. Chennai: Madras Medical College; 2017.
27. Chung KJ, De Sarno D, Lee TY. Quantitative functional imaging with CT perfusion: technical considerations, kinetic modeling, and applications. Front Phys. 2023;11:1246973.
28. Talybov R, Trofimova T, Mochalov V, Karasev S, Gorshkova V, Kleschevnikova T, et al. The determination of the boundaries and prediction the radicality of glioblastoma resection using MRI and CT perfusion. Front Neurol. 2025;16:1572845.
29. Kaichi Y, Tatsugami F, Nakamura Y, Baba Y, Iida M, Higaki T, et al. Improved differentiation between high- and low-grade gliomas by combining dual-energy CT analysis and perfusion CT. Medicine. 2018;97(32):e11670.
30. Sabeghi P, Zarand P, Zargham S, Golestany B, Shariat A, Chang M, et al. Advances in neuro-oncological imaging: an update on diagnostic approach to brain tumors. Cancers. 2024;16(3):576.
31. Xyda A, Haberland U, Klotz E, Bock HC, Jung K, Knauth M, et al. Brain volume perfusion CT performed with 128-detector row CT system in patients with cerebral gliomas: a feasibility study. Eur Radiol. 2011;21(9):1811-9.
32. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, et al. Acute stroke imaging research roadmap. Stroke. 2008;39(5):1621-8.
33. Sanelli PC, Lev MH, Eastwood JD, Gonzalez RG, Lee TY. The effect of varying user-selected input parameters on quantitative values in CT perfusion maps. Acad Radiol. 2004;11(10):1085-92.